Filings & corporate actions
66 results filed
CSVNext results · Q2 FY27
Expected 10 Nov 2026 – 15 Nov 2026
Estimate: filed 41–46 days after quarter end, last 5 times
Dividend
₹0.50 per share · last 20 Sept 2019
2026
- 13 AugresultsResults · Q1 FY27 · consolidated and standalone-5.0%NSE
- 8 JulshareholdingShareholding · 30 Jun 2026-1.3%NSE
- 15 MayresultsResults · Q4 FY26 · consolidated and standalone+10.0%NSE
- 16 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
- 24 MarbonusBonus issue · factor 2.00-2.6%
- 11 FebresultsResults · Q3 FY26 · consolidated and standalone-9.8%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-3.5%NSE
Reaction to results · all yearsrose on day 0 in 20 of 65 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 13 Aug 2026 | -5.0% | -15.1% | -2.7% | 0.3× |
| Q4 FY26 | 15 May 2026 | +10.0% | +20.5% | +20.7% | 22.4× |
| Q3 FY26 | 11 Feb 2026 | -9.8% | -13.2% | -15.1% | 4.6× |
| Q2 FY26 | 13 Nov 2025 | -2.2% | +0.3% | -7.1% | 0.9× |
| Q1 FY26 | 13 Aug 2025 | -2.0% | -7.0% | -17.9% | 2.1× |
| Q4 FY25 | 19 May 2025 | +7.2% | +11.0% | +3.6% | 5.2× |
| Q3 FY25 | 11 Feb 2025 | +0.2% | +2.8% | -1.9% | 2.0× |
| Q2 FY25 | 12 Nov 2024 | +9.4% | +3.1% | +8.3% | 46.2× |
| Q1 FY25 | 8 Aug 2024 | -3.8% | -3.9% | -1.7% | 0.4× |
| Q4 FY24 | 28 May 2024 | +0.7% | -6.0% | -0.4% | 2.9× |
| Q3 FY24 | 8 Feb 2024 | -5.0% | -9.2% | -19.8% | 0.4× |
| Q2 FY24 | 10 Nov 2023 | +2.0% | +0.4% | +7.9% | 0.5× |
| Q1 FY24 | 12 Aug 2023 | -0.6% | -4.1% | +14.3% | 0.2× |
| Q4 FY23 | 30 May 2023 | -3.1% | -0.4% | -9.6% | 0.1× |
| Q3 FY23 | 15 Feb 2023 | -1.2% | -2.0% | -1.0% | 0.6× |
| Q2 FY23 | 15 Nov 2022 | -3.3% | -6.1% | -7.4% | 1.2× |
| Q1 FY23 | 11 Aug 2022 | +1.1% | +3.9% | +9.2% | 0.9× |
| Q4 FY22 | 27 May 2022 | +1.6% | +7.6% | -0.3% | 0.3× |
| Q3 FY22 | 15 Feb 2022 | -4.9% | -16.5% | -14.1% | 5.8× |
| Q2 FY22 | 12 Nov 2021 | +1.6% | -10.6% | -1.3% | 2.3× |
| Q1 FY22 | 13 Aug 2021 | -3.5% | -14.4% | -7.2% | 0.4× |
| Q4 FY21 | 23 Jun 2021 | +4.8% | -1.8% | +20.3% | 2.7× |
| Q3 FY21 | 12 Feb 2021 | -3.5% | -6.0% | -13.8% | 3.0× |
| Q2 FY21 | 14 Nov 2020 | -1.7% | -6.4% | -5.1% | 0.3× |
| Q1 FY21 | 16 Sept 2020 | -2.6% | -13.0% | +14.4% | 0.4× |
| Q4 FY20 | 1 Jul 2020 | -4.4% | -6.7% | -10.3% | 0.2× |
| Q3 FY20 | 15 Feb 2020 | -2.0% | -7.3% | -23.9% | 0.7× |
| Q2 FY20 | 10 Jan 2020 | +0.1% | +4.5% | -2.6% | 0.3× |
| Q1 FY20 | 14 Aug 2019 | -10.0% | -23.1% | -10.7% | 1.2× |
| Q4 FY19 | 27 Jun 2019 | -4.2% | -5.3% | -24.5% | 0.6× |
| Q3 FY19 | 27 Feb 2019 | -3.4% | +6.9% | +3.2% | 0.7× |
| Q3 FY18 | 28 Jan 2019 | +0.8% | +1.4% | -7.1% | 0.3× |
| Q2 FY19 | 19 Nov 2018 | -3.7% | -3.6% | -11.4% | 0.4× |
| Q1 FY19 | 30 Aug 2018 | -0.6% | -8.5% | +3.3% | 0.4× |
| Q4 FY18 | 20 Jun 2018 | -0.2% | -5.3% | -4.8% | 0.4× |
| Q2 FY18 | 22 Nov 2017 | -3.4% | 0.0% | +1.0% | 2.0× |
| Q1 FY18 | 5 Oct 2017 | +1.7% | +3.2% | +11.4% | 2.3× |
| Q4 FY17 | 17 Jun 2017 | -0.4% | -2.6% | -2.4% | 0.1× |
| Q3 FY17 | 17 Feb 2017 | +2.6% | -0.6% | +0.4% | 1.7× |
| Q2 FY17 | 18 Nov 2016 | -3.4% | +9.7% | +8.6% | 0.3× |
| Q1 FY17 | 26 Aug 2016 | -0.9% | -0.9% | +45.0% | 0.4× |
| Q4 FY16 | 13 Jun 2016 | -0.3% | -6.0% | -0.3% | 0.2× |
| Q3 FY16 | 13 Feb 2016 | +12.1% | +6.5% | +11.5% | 1.1× |
| Q2 FY16 | 13 Nov 2015 | -4.8% | -3.0% | +8.6% | 0.1× |
| Q1 FY16 | 28 Aug 2015 | -1.6% | -11.0% | -4.4% | 0.3× |
| Q4 FY15 | 1 Jun 2015 | -1.0% | -5.5% | -4.1% | 0.3× |
| Q3 FY15 | 19 Feb 2015 | -1.6% | -6.1% | -14.4% | 0.7× |
| Q2 FY15 | 21 Nov 2014 | -0.3% | +37.3% | +32.2% | 2.0× |
| Q1 FY15 | 20 Aug 2014 | +20.0% | +35.1% | +33.3% | 31.1× |
| Q4 FY14 | 3 Jun 2014 | +1.3% | +34.2% | +12.2% | 0.7× |
| Q3 FY14 | 20 Feb 2014 | -2.2% | -2.2% | +13.3% | 0.3× |
| Q2 FY14 | 22 Nov 2013 | -4.0% | -2.0% | +7.0% | 0.6× |
| Q1 FY14 | 21 Aug 2013 | -0.5% | +8.8% | +22.5% | 2.1× |
| Q4 FY13 | 21 Jun 2013 | -3.0% | -2.1% | -6.0% | 1.4× |
| Q3 FY13 | 22 Feb 2013 | -0.7% | -23.3% | -28.4% | 0.6× |
| Q2 FY13 | 10 Nov 2012 | -2.4% | -7.6% | -5.0% | 0.7× |
| Q1 FY13 | 29 Aug 2012 | +2.2% | +26.7% | -32.7% | 1.4× |
| Q4 FY12 | 14 May 2012 | -3.7% | -25.8% | -11.5% | 0.0× |
| Q3 FY12 | 6 Feb 2012 | 0.0% | +12.4% | +16.4% | 1.7× |
| Q2 FY12 | 17 Nov 2011 | -3.8% | -6.5% | -15.9% | 1.4× |
| Q1 FY12 | 17 Aug 2011 | +4.3% | +0.7% | +29.0% | 0.3× |
| Q4 FY11 | 14 May 2011 | 0.0% | +2.6% | +3.2% | 0.4× |
| Q3 FY11 | 14 Feb 2011 | -4.7% | -12.3% | -25.1% | 0.6× |
| Q2 FY11 | 12 Nov 2010 | +1.4% | -8.3% | -14.4% | 0.5× |
| Q1 FY11 | 28 Sept 2010 | — | — | — | — |
| Average | -0.6% | -1.3% | -0.4% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+4.0%
Profit YoY-13.0%
Interest cost YoY+1.4%
Revenue QoQ-49.9%
Profit QoQ-86.8%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +25.2% | +18.5% | +16.7% | +24.9% | +28.3% | — |
| Profit | +65.8% | +44.9% | +41.8% | +38.1% | — | — |
Key data
CSVOpen244.00
Day range236.30 – 267.80
52-week range117.25 – 267.80
From 52w high-2.7%
RSI (14)82.0
ATR (14)13.03
Volume6.62L
Avg volume (20D)71.5K
Rel volume9.26×
Volatility (1Y)47.5%
Turnover₹17.3Cr
SMA 50 / 200190.11 / 172.59
Delivery percentage
Latest · 6 Oct 202634.6%
20-day avg93.6%
1-year avg65.4%
Percentile (own history)4th
Range18.1–100.0%
Sessions1,719
Over the last 20 sessions KILITCH settled 93.6% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 65.4%, so recent sessions are running 28.3 points higher than usual. The latest session ranks higher than 4% of the 1,719 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryPharmaceuticals
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +11.53% | +20.11% | +51.11% | +40.58% | +88.03% | +52.99% |
Valuation
CSVMarket cap₹911 Cr
P/E (TTM)31.2
EPS (TTM)8.35
Shares outstanding3.50Cr
Listed29 Sept 2010
Ownership
CSVPromoter63.77%
Promoter Δ QoQ0.00 pp
Public36.23%
FII0.12%
DII0.00%
Pledged0.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 48.9 | 53.8 | 89.6 | 44.9 |
| YoY chg | +3.1% | -4.2% | +46.3% | +4.0% |
| Net profit (₹ Cr) | 8.0 | 4.3 | 14.9 | 2.0 |
| YoY chg | -6.6% | -23.1% | +45.6% | -13.0% |
| Net margin | 16.4% | 8.0% | 16.6% | 4.4% |
| EPS | 2.48 | 1.25 | 4.24 | 0.83 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 63.77% · public 36.23%2021-092026-06
- Promoter
- Public and others
- Promoter
- 63.77%
- Public
- 36.23%
- Promoter change
- 0.00 pp
- Filed
- 8 Jul 2026
- FII
- 0.12%
- DII
- 0.00%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 41.2 | 31.8 | 44.8 | 33.5 | 47.5 | 56.2 | 61.2 | 43.1 | 48.9 | 53.8 | 89.6 | 44.9 | |
| Other income | 0.5 | 3.0 | 0.5 | 2.6 | 5.2 | 1.7 | 1.7 | 2.6 | 6.7 | 1.5 | 0.5 | 2.9 | |
| Total income | 41.7 | 34.8 | 45.3 | 36.0 | 52.6 | 57.9 | 62.9 | 45.7 | 55.6 | 55.3 | 90.1 | 47.8 | |
| Total expenses | 34.9 | 31.9 | 40.0 | 34.4 | 42.3 | 49.6 | 49.1 | 42.2 | 46.2 | 49.7 | 69.9 | 43.9 | |
| └ Finance costs | 1.5 | 1.6 | 1.3 | 1.7 | 0.3 | 1.4 | 1.6 | 1.5 | 1.4 | 1.1 | 1.4 | 0.9 | |
| └ Depreciation | 0.8 | 0.8 | 0.9 | 0.9 | 0.6 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | |
| Profit before tax | 6.8 | 2.8 | 5.3 | 1.7 | 10.3 | 8.3 | 13.8 | 3.4 | 9.4 | 5.6 | 20.2 | 3.9 | |
| Tax expense | 1.7 | 1.1 | 1.6 | 1.5 | 1.7 | 2.6 | 3.6 | 1.2 | 1.4 | 1.3 | 5.3 | 1.9 | |
| Net profit | 5.1 | 1.7 | 3.7 | 0.1 | 8.6 | 5.6 | 10.2 | 2.3 | 8.0 | 4.3 | 14.9 | 2.0 | |
| EPS | 1.47 | 0.93 | 1.12 | 0.41 | 2.68 | 1.85 | 3.23 | 0.94 | 2.48 | 1.25 | 4.24 | 0.83 | |
| Net margin | 12.36% | 5.48% | 8.21% | 0.33% | 18.14% | 10.00% | 16.69% | 5.24% | 16.43% | 8.02% | 16.61% | 4.38% | |
| PBT margin | 16.46% | 8.88% | 11.82% | 4.93% | 21.79% | 14.69% | 22.61% | 7.99% | 19.21% | 10.40% | 22.56% | 8.61% | |
| Tax rate | 24.91% | 38.30% | 30.51% | 93.22% | 16.77% | 31.95% | 26.19% | 34.40% | 14.46% | 22.89% | 26.36% | 49.07% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 13 Aug 2026.
KILITCH at a glance
- KILITCH closed at ₹260.7 on 6 Oct 2026, +11.53% on the day, +53.0% over one year, 2.7% below its 52-week high of ₹267.8.
- Delivery was 34.6% of traded quantity on 6 Oct 2026, the 4th percentile of its own 1,719 sessions with a reading (20-session average 93.6%, 1-year average 65.4%).
- Market capitalisation is ₹911 crore at a trailing P/E of 31.2 (trailing EPS ₹8.35).
- Q1 FY27 results (consolidated, filed 13 Aug 2026): revenue ₹45 crore (+4.0% year on year), net profit ₹2 crore (-13.0%); the price moved -5.0% on the first session after.
- Promoters held 63.77% at 30 Jun 2026, unchanged on the previous filing.
- Q2 FY27 results are expected between 10 Nov 2026 and 15 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryPharmaceuticals
ISININE729D01010
SeriesEQ
Listed29 Sept 2010
History from29 Sept 2010
Sessions3,958
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Pharmaceuticals & Biotechnology
CSV- DIVISLABDivi's Laboratories Limited9,550.00+3.85%
- LAURUSLABSLaurus Labs Limited2,050.00+3.99%
- SUNPHARMASun Pharmaceutical Industries Limited1,804.10+1.37%
- WOCKPHARMAWockhardt Limited2,176.40+5.47%
- DRREDDYDr. Reddy's Laboratories Limited1,208.00+0.42%
- MOREPENLABMorepen Laboratories Limited143.96+6.41%
- ZYDUSLIFEZydus Lifesciences Limited1,159.50+1.80%
- SYMBIOTECSYMBIOTEC1,149.50-1.73%
- TORNTPHARMTorrent Pharmaceuticals Limited4,772.000.00%
- GLANDGland Pharma Limited3,006.10+3.25%
- LUPINLupin Limited2,029.30+0.91%
- AUROPHARMAAurobindo Pharma Limited1,692.80+1.07%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE